142 related articles for article (PubMed ID: 7525096)
1. Comparative genotoxicity of 2,3'-O-cyclocytidine, beta-xylocytidine and 1-beta-D-arabinofuranosylcytosine in human tumor cell lines.
Mirzayans R; Cubitt S; Enns L; Karimian K; Radatus B; Hirani-Hojatti S; Murthy K; Paterson MC
Carcinogenesis; 1994 Oct; 15(10):2319-24. PubMed ID: 7525096
[TBL] [Abstract][Full Text] [Related]
2. Effect of DNA polymerase inhibitors on repair of gamma ray-induced DNA damage in proliferating (intact versus permeable) human fibroblasts: evidence for differences in the modes of action of aphidicolin and 1-beta-D-arabinofuranosylcytosine.
Mirzayans R; Enns L; Cubitt S; Karimian K; Radatus B; Paterson MC
Biochim Biophys Acta; 1994 Oct; 1227(1-2):92-100. PubMed ID: 7918688
[TBL] [Abstract][Full Text] [Related]
3. Complementary antineoplastic activity of the cytosine nucleoside analogues troxacitabine (Troxatyl) and cytarabine in human leukemia cells.
Bouffard DY; Jolivet J; Leblond L; Hamelin B; Ouellet F; Barbeau S; Richard A; Gourdeau H
Cancer Chemother Pharmacol; 2003 Dec; 52(6):497-506. PubMed ID: 12955470
[TBL] [Abstract][Full Text] [Related]
4. Determinants of sensitivity to 1-beta-D-arabinofuranosylcytosine in HCT 116 and NCI-H630 human colon carcinoma cells.
Grem JL; Geoffroy F; Politi PM; Cuddy DP; Ross DD; Nguyen D; Steinberg SM; Allegra CJ
Mol Pharmacol; 1995 Aug; 48(2):305-15. PubMed ID: 7651364
[TBL] [Abstract][Full Text] [Related]
5. Synergistic effect of aphidicolin and 1-beta-D-arabinofuranosylcytosine on the repair of gamma-ray-induced DNA damage in normal human fibroblasts.
Mirzayans R; Andrais B; Paterson MC
Int J Radiat Biol; 1992 Oct; 62(4):417-25. PubMed ID: 1357055
[TBL] [Abstract][Full Text] [Related]
6. Induction of differentiation of acute promyelocytic leukemia cells by a cytidine deaminase-resistant analogue of 1-beta-D-arabinofuranosylcytosine, 1-(2-deoxy-2-methylene-beta-D-erythro-pentofuranosyl)cytidine.
Niitsu N; Ishii Y; Matsuda A; Honma Y
Cancer Res; 2001 Jan; 61(1):178-85. PubMed ID: 11196157
[TBL] [Abstract][Full Text] [Related]
7. Cyclopentenyl cytosine increases the phosphorylation and incorporation into DNA of 1-beta-D-arabinofuranosyl cytosine in a human T-lymphoblastic cell line.
Verschuur AC; Van Gennip AH; Leen R; Voûte PA; Brinkman J; Van Kuilenburg AB
Int J Cancer; 2002 Apr; 98(4):616-23. PubMed ID: 11920624
[TBL] [Abstract][Full Text] [Related]
8. Cyclopentenyl cytosine primes SK-N-BE(2)c neuroblastoma cells for cytarabine toxicity.
Bierau J; Van Gennip AH; Leen R; Helleman J; Caron HN; Van Kuilenburg AB
Int J Cancer; 2003 Jan; 103(3):387-92. PubMed ID: 12471622
[TBL] [Abstract][Full Text] [Related]
9. Induction and repair of DNA strand breaks and 1-beta-D-arabinofuranosylcytosine-detectable sites in 40-75 kVp X-irradiated compared to 60Co gamma-irradiated human cell lines.
Mirzayans R; Waters R; Paterson MC
Radiat Res; 1988 Apr; 114(1):168-85. PubMed ID: 3353503
[TBL] [Abstract][Full Text] [Related]
10. Cyclopentenyl cytosine induces apoptosis and increases cytarabine-induced apoptosis in a T-lymphoblastic leukemic cell-line.
Verschuur AC; Brinkman J; Van Gennip AH; Leen R; Vet RJ; Evers LM; Voûte PA; Van Kuilenburg AB
Leuk Res; 2001 Oct; 25(10):891-900. PubMed ID: 11532523
[TBL] [Abstract][Full Text] [Related]
11. Metronidazole enhances the cytotoxic synergism produced by the combination of 1-beta-arabinofuranosylcytosine and cis-diamminedichloroplatinum.
Trujillo JM; Yang LY; Gercovich G; Su YZ; Lee J
Anticancer Res; 1989; 9(6):1751-6. PubMed ID: 2627125
[TBL] [Abstract][Full Text] [Related]
12. Toxic interaction between hydroxyurea and 1-beta-D-arabino-furanosylcytosine on the DNA of a human hepatoma cell line (HEPG2).
Severin I; Padieu M; Lhuguenot JC; Chagnon MC
Toxicol Lett; 2003 Dec; 145(3):303-11. PubMed ID: 14580901
[TBL] [Abstract][Full Text] [Related]
13. Comparative study of a novel nucleoside analogue (Troxatyl, troxacitabine, BCH-4556) and AraC against leukemic human tumor xenografts expressing high or low cytidine deaminase activity.
Gourdeau H; Bibeau L; Ouellet F; Custeau D; Bernier L; Bowlin T
Cancer Chemother Pharmacol; 2001 Mar; 47(3):236-40. PubMed ID: 11320667
[TBL] [Abstract][Full Text] [Related]
14. Intracellular pharmacodynamic studies of the synergistic combination of 6-mercaptopurine and cytosine arabinoside in human leukemia cell lines.
Ramilo-Torno LV; Avramis VI
Cancer Chemother Pharmacol; 1995; 35(3):191-9. PubMed ID: 7805176
[TBL] [Abstract][Full Text] [Related]
15. Comparative studies on repair inhibition by araA, araC and aphidicolin of radiation induced DNA and chromosome damage in rodent cells: comparison with fixation of PLD.
Iliakis G; Pantelias G; Okayasu R; Seaner R
Int J Radiat Oncol Biol Phys; 1989 May; 16(5):1261-5. PubMed ID: 2497095
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of synergism of drugs cis-diamminedichloroplatinum (II) and arabinosylcytosine on the level of chemical interaction with DNA and on the growth of mouse leukemia.
Rauko P; Novotný L; Reichelová V; Balázová E
Gen Pharmacol; 1991; 22(5):805-10. PubMed ID: 1761184
[TBL] [Abstract][Full Text] [Related]
17. Long intracellular retention of 4'-thio-arabinofuranosylcytosine 5'-triphosphate as a critical factor for the anti-solid tumor activity of 4'-thio-arabinofuranosylcytosine.
Someya H; Waud WR; Parker WB
Cancer Chemother Pharmacol; 2006 Jun; 57(6):772-80. PubMed ID: 16180016
[TBL] [Abstract][Full Text] [Related]
18. Metabolism, incorporation into DNA, and interactions with 1-beta-D-arabinofuranosylcytosine of 5-hydroxymethyl-2'-deoxyuridine in human promyelocytic leukemia cells (HL-60).
Vilpo JA; Vilpo LM
Cancer Res; 1988 Jun; 48(11):3117-22. PubMed ID: 3163271
[TBL] [Abstract][Full Text] [Related]
19. Effects of protein kinase C inhibitor, staurosporine derivative CGP 41 251, on cell cycle, DNA synthesis and drug uptake in neoplastic cell lines.
Sedlak J; Hunakova L; Duraj J; Chorvath B; Novotny L
Anticancer Drugs; 1995 Feb; 6(1):70-6. PubMed ID: 7756686
[TBL] [Abstract][Full Text] [Related]
20. Faulty DNA polymerase delta/epsilon-mediated excision repair in response to gamma radiation or ultraviolet light in p53-deficient fibroblast strains from affected members of a cancer-prone family with Li-Fraumeni syndrome.
Mirzayans R; Enns L; Dietrich K; Barley RD; Paterson MC
Carcinogenesis; 1996 Apr; 17(4):691-8. PubMed ID: 8625479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
